Indian equities are experiencing significant volatility, with the Sensex showing 1,000-point swings. However, five stocks are standing out by maintaining their value and even increasing it. Lupin, trading at ₹2,335, is nearing its 52-week high of ₹2,376, and has seen an 11% gain so far in 2026, bolstered by a strategic acquisition of VISUfarma B.V. in the Netherlands. Sun Pharma, India's largest pharmaceutical company, is trading at ₹1,795 and has gained 5% this year, focusing on specialty drugs to mitigate pricing pressures. Torrent Pharma is trading around ₹4,266, close to its 52-week high, and has experienced a 32% increase over the past year, with strong growth expected from its India operations. CCL Products, an instant coffee exporter, reports robust performance with sales and profit growing at CAGRs of 22% and 13% respectively, while also anticipating 15-20% EBITDA growth for FY26. The resilience of these stocks suggests stronger earnings visibility and institutional support, making them potential candidates for market leadership in the future.